These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1455401)

  • 1. The influence of glycosylation on the catalytic and fibrinolytic properties of pro-urokinase.
    Lenich C; Pannell R; Henkin J; Gurewich V
    Thromb Haemost; 1992 Nov; 68(5):539-44. PubMed ID: 1455401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylation of prourokinase produced by Pichia pastoris impairs enzymatic activity but not secretion.
    Wang P; Zhang J; Sun Z; Chen Y; Liu JN
    Protein Expr Purif; 2000 Nov; 20(2):179-85. PubMed ID: 11049742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical properties of recombinant mutants of nonglycosylated single chain urokinase-type plasminogen activator.
    Li XK; Lijnen HR; Nelles L; Hu MH; Collen D
    Biochim Biophys Acta; 1992 Sep; 1159(1):37-43. PubMed ID: 1390910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).
    Gurewich V; Pannell R; Broeze RJ; Mao J
    J Clin Invest; 1988 Dec; 82(6):1956-62. PubMed ID: 2974047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glycosylation at Asn302 of pro-urokinase on its stability in culture supernatant.
    Yang B; Li TD
    Chin Med Sci J; 2006 Jun; 21(2):128-30. PubMed ID: 16845803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic and fibrinolytic properties of recombinant urokinase plasminogen activator from E. coli, mammalian, and yeast cells.
    Wang P; Zhang J; Sun Z; Chen Y; Gurewich V; Liu JN
    Thromb Res; 2000 Dec; 100(5):461-7. PubMed ID: 11150590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.
    Gurewich V; Pannell R; Louie S; Kelley P; Suddith RL; Greenlee R
    J Clin Invest; 1984 Jun; 73(6):1731-9. PubMed ID: 6725557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renaturation of recombinant human pro-urokinase expressed in Escherichia coli.
    Hua ZC; Dong C; Zhu DX
    Biochem Biophys Res Commun; 1996 Mar; 220(1):131-6. PubMed ID: 8602832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A site-directed mutagenesis of pro-urokinase which substantially reduces its intrinsic activity.
    Liu JN; Tang W; Sun ZY; Kung W; Pannell R; Sarmientos P; Gurewich V
    Biochemistry; 1996 Nov; 35(45):14070-6. PubMed ID: 8916892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology.
    Zamarron C; Lijnen HR; Van Hoef B; Collen D
    Thromb Haemost; 1984 Aug; 52(1):19-23. PubMed ID: 6495259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
    Liu JN; Gurewich V
    Biochemistry; 1992 Jul; 31(27):6311-7. PubMed ID: 1385727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R; Black J; Gurewich V
    J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of plasminogen by pro-urokinase. I. Mechanism.
    Lijnen HR; Zamarron C; Blaber M; Winkler ME; Collen D
    J Biol Chem; 1986 Jan; 261(3):1253-8. PubMed ID: 2935528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific fibrinolytic properties of different molecular forms of pro-urokinase from a monkey kidney cell culture.
    Rijken DC; Binnema DJ; Los P
    Thromb Res; 1986 Jun; 42(6):761-8. PubMed ID: 2425448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN; Gurewich V
    J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro renaturation of recombinant human pro-urokinase expressed in Escherichia coli.
    Zhu H; Liu W; Shi W; Xue Y; Kuai L; Ma Z
    Chin Med J (Engl); 2001 Feb; 114(2):186-90. PubMed ID: 11780204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--IV. Variability in fibrinolytic response of plasma of several mammalian species.
    Lijnen HR; De Wreede K; Demarsin E; Collen D
    Thromb Haemost; 1984 Aug; 52(1):31-3. PubMed ID: 6495261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase.
    Liu JN; Pannell R; Gurewich V
    J Biol Chem; 1992 Aug; 267(22):15289-92. PubMed ID: 1639775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion expression of human pro-urokinase with E. coli thioredoxin.
    Sun AL; Hua ZC; Yao J; Yang YH; Yin DQ
    Biochem Mol Biol Int; 1998 Oct; 46(3):479-86. PubMed ID: 9818087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and characterization of recombinant human micro-plasminogen.
    Ma Z; Lu W; Wu S; Chen J; Sun Z; Liu JN
    Biotechnol Lett; 2007 Apr; 29(4):517-23. PubMed ID: 17206368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.